Company newsForm 8-K and release
Bruker BRKR
Bruker appoints Eicke Latz to its board, effective January 1, 2027
The board also declared a quarterly cash dividend of $0.05 per share, payable January 7, 2027.
GetSignal
On November 13, 2026, Bruker's board approved adding one seat, bringing the board to twelve directors, and appointed Eicke Latz, MD PhD, to fill the new seat, effective January 1, 2027. Bruker said Latz will initially serve as a director until the 2029 Annual Meeting of Stockholders, in Class II.
Bruker said Latz's director compensation will be consistent with that of its other non-employee directors, as described in its 2026 proxy statement. Bruker said it will file an amended Form 8-K to disclose his committee assignments once they are determined.
Chairman, President and CEO Frank H. Laukien said Latz's disease biology leadership, biopharma experience and medical institute leadership would be valuable to the board as Bruker expands its work in post-genomic life-science tools, molecular diagnostics and drug discovery.
Latz is Scientific Director of the German Rheumatology Research Center and Professor of Experimental Rheumatology at Charité Universitätsmedizin Berlin. He has co-founded five biotechnology companies, including IFM Therapeutics, Odyssey Therapeutics, Metaimmune Therapeutics, DiosCure Therapeutics and Beren Therapeutics.
On November 12, 2026, the board declared a quarterly cash dividend of $0.05 per share on Bruker's common stock, payable January 7, 2027, to shareholders of record at the close of business on December 21, 2026.
Key facts
- Effective
- January 1, 2027
- Board size
- Twelve directors
- Initial term ends
- 2029 Annual Meeting of Stockholders
- Quarterly dividend
- $0.05 per share
- Dividend record date
- December 21, 2026
- Dividend payable
- January 7, 2027
Sources: Form 8-K filed November 16, 2026, and the company's release on Business Wire, November 16, 2026.
Written by GetSignal with AI from the company's press release. How we make news
Not investment advice.
More company news
Bruker first, then the newest- Uber Technologies makes Zoox robotaxis available on its Las Vegas platform
UBER · Uber Technologies · Company release · Nov 16, 2026
- Canadian Natural Resources agrees to acquire Advantage Energy
CNQ · Canadian Natural Resources · Company release · Nov 16, 2026
- Rio Tinto, BCL and ABG agree to establish fund for Panguna mine legacy impacts
RIO · Rio Tinto Group · Company release · Nov 16, 2026
- Viking Therapeutics shares VK2735 obesity trial analysis at ObesityWeek 2026
VKTX · Viking Therapeutics · Company release · Nov 15, 2026
